Loading market data...
GrantExec
GrantExec

Questions? Contact Us

ยฉ 2025 GrantExec. All rights reserved.

SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1 Clinical Trial Not Allowed)

This funding opportunity provides financial support to small businesses developing innovative health-related technologies, helping them advance their projects toward commercialization through technical assistance and late-stage development activities.

Contact for amount
Forecasted
Nationwide
Grant Description

The National Institutes of Health (NIH), a component of the U.S. Department of Health and Human Services, has released a forecast for an upcoming funding opportunity titled the SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development. This program is designed to support the transition of SBIR and STTR Phase II and Phase IIB projects toward commercialization. It targets small business concerns (SBCs) that are developing innovative health-related technologies and need additional support for later-stage research and development. The purpose of this funding opportunity is to provide technical assistance and support for activities not typically covered in earlier SBIR/STTR phases. These may include tasks such as independent replication of studies, regulatory support, clinical studies, manufacturing, and Investigational New Drug (IND)-enabling studies. This initiative is intended to bolster efforts that advance the commercialization potential of previously or currently funded projects. While subcontracting is permitted, SBCs are required to retain control and oversight of the funded research and development efforts. Eligible applicants include U.S.-based small business concerns that have had an active NIH SBIR or STTR Phase II or Phase IIB contract, grant, or cooperative agreement within the past 36 months. These SBCs must meet the structural and ownership requirements laid out in the eligibility section, including criteria on business formation, U.S. economic contribution, and ownership by U.S. citizens or qualifying venture entities. Special guidelines are outlined for businesses owned by multiple investment firms or operating under joint ventures. This is a discretionary grant forecast under several NIH Assistance Listings, covering a wide range of health research areas, including but not limited to cardiovascular, cancer, mental health, infectious diseases, aging, and child health research. The opportunity is anticipated to be posted on October 1, 2025, with applications due by January 5, 2026. Awards are expected to be issued on June 1, 2026, with project start dates beginning July 1, 2026. It is important to note that this grant does not allow for clinical trials under the SB1 activity code and its availability is contingent on reauthorization of the SBIR program. The opportunity is still in its forecast stage and is not currently accepting applications. Interested SBCs are encouraged to begin forming partnerships and preparing relevant documentation to ensure responsiveness to the forthcoming Notice of Funding Opportunity (NOFO). The NIHโ€™s Small Business Education and Entrepreneurial Development (SEED) Office is available for inquiries related to this forecast via email at SEEDinfo@nih.gov or by phone at 301-827-8595.

Funding Details

Award Range

Not specified - Not specified

Total Program Funding

Not specified

Number of Awards

Not specified

Matching Requirement

No

Additional Details

Funding will support late-stage development and technical assistance. CRP awards may include costs for studies, manufacturing, regulatory submissions, and similar commercialization activities. One award is allowed per project. Significant subcontracting is permitted but the SBC must retain R&D oversight.

Eligibility

Eligible Applicants

Small businesses

Additional Requirements

Only United States small business concerns (SBCs) that have had an active NIH SBIR or STTR Phase II or Phase IIB contract, grant or cooperative agreement from NIH within the last 36 months are eligible to submit applications for this opportunity. Only one CRP award is allowed per project. SBCs with currently active and newly awarded Phase II or Phase IIB awards from one of the participating ICs are also eligible. A small business concern is one that, at the time of award of Phase I and Phase II, meets all of the following criteria: Is organized for profit, with a place of business located in the United States, which operates primarily within the United States or which makes a significant contribution to the United States economy through payment of taxes or use of American products, materials or labor. Is in the legal form of an individual proprietorship, partnership, limited liability company, corporation, joint venture, association, trust or cooperative, except that where the form is a joint venture, there must be less than 50 percent participation by foreign business entities in the joint venture. Must be one of the following: a. Be a concern which is more than 50% directly owned and controlled by one or more individuals (who are citizens or permanent resident aliens of the United States), other business concerns (each of which is more than 50% directly owned and controlled by individuals who are citizens or permanent resident aliens of the United States), an Indian tribe, ANC or NHO (or a wholly owned business entity of such tribe, ANC or NHO), or any combination of these; OR b. Be a concern which is more than 50% owned by multiple venture capital operating companies, hedge funds, private equity firms, or any combination of these. No single venture capital operating company, hedge fund, or private equity firm may own more than 50% of the concern, unless that single venture capital operating company, hedge fund, or private equity firm qualifies as a small business concern that is more than 50% directly owned and controlled by individuals who are citizens or permanent resident aliens of the United States; OR c. Be a joint venture in which each entity to the joint venture must meet the requirements set forth in paragraph 3 (a) or 3 (b) of this section. A joint venture that includes one or more concerns that meet the requirements of paragraph (b) of this section must comply with 121.705(b) concerning registration and proposal requirements. Has, including its affiliates, not more than 500 employees. If the concern is more than 50% owned by multiple venture capital operating companies, hedge funds, private equity firms, or any combination of these falls under 3 (b) or 3 (c) above, see Section IV. Application and Submission Information for additional instructions regarding required application certification. If an Employee Stock Ownership Plan owns all or part of the concern, each stock trustee and plan member is considered an owner. If a trust owns all or part of the concern, each trustee and trust beneficiary is considered an owner. Definitions: Hedge fund has the meaning given that term in section 13(h)(2) of the Bank Holding Company Act of 1956 (12 U.S.C. 1851(h)(2)). The hedge fund must have a place of business located in the United States and be created or organized in the United States, or under the law of the United States or of any State. Portfolio company means any company that is owned in whole or part by a venture capital operating company, hedge fund, or private equity firm. Private equity firm has the meaning given the term private equity fund in section 13(h)(2) of the Bank Holding Company Act of 1956 (12 U.S.C. 1851(h)(2)). The private equity firm must have a place of business located in the United States and be created or organized in the United States, or under the law of the United States or of any State. Venture capital operating company means an en

Geographic Eligibility

All

Expert Tips

Applicants are encouraged to start planning collaborations and project design in advance. Be aware that publication of this NOFO depends on the reauthorization of the SBIR program.

Key Dates

Application Opens

October 1, 2025

Application Closes

January 5, 2026

Contact Information

Grantor

US Department of Health & Human Services (National Institutes of Health)

Subscribe to view contact details

Newsletter Required
Categories
Health
Science and Technology